by Ryan Paolicelli | Sep 29, 2023
Patrick Holmes, Senior Director, Global Innovation Policy and Geopolitical Risk Lead, heads a team with responsibility for developing global health policy initiatives and evidence across a series of policy issues in support of Pfizer’s R&D-driven organization....
by Ryan Paolicelli | Feb 23, 2023
Nácia Pupo Taylor leads initiatives focused on health systems sustainability, global health security, anti-microbial resistance, emerging infectious diseases, and vaccines. Nácia is passionate about improving healthcare for everyone, everywhere and a strong believer...
by Ryan Paolicelli | Feb 23, 2023
Michael Lobritz is the Head of Infectious Diseases Early Development at F. Hoffmann-La Roche, Ltd, based in Basel, Switzerland. His group is responsible for the translational development of Roche antibiotics and antivirals from Phase 0 through Phase 2, including the...
by Ryan Paolicelli | Feb 23, 2023
Currently, Global Therapeutic Area Head for Infectious Diseases at Menarini Group. His over 25 years’ experience and expertise in Pharma covers various disease fields including CNS, Gastroenterology, Bone diseases, oncology and infectious disease including vaccines...
by Ryan Paolicelli | Feb 23, 2023
Greg Frank serves as Director of Global Public Policy for MSD.
